Avidity Biosciences, Inc.
NASDAQ:RNA
30.58 (USD) • At close May 23, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.573 | 2.973 | 2.336 | 2.045 | 3.543 | 2.193 | 2.818 | 2.316 | 2.233 | 2.769 | 2.482 | 2.178 | 1.795 | 1.852 | 2.163 | 2.607 | 2.704 | 2.142 | 1.746 | 1.541 | 1.358 | 1.445 | 0.65 | 0.224 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.687 | 0.641 | 0.615 | 1.3 | 1.261 | 1.079 | 0.381 | 0.4 | 39.789 | 0.314 | 0.208 | 24.831 | 22.706 | 20.677 | 13.619 | 9.455 | 8.984 | 5.544 | 5.645 | 5.099 | 2.533 | 1.262 |
| Gross Profit
| 0 | 2.235 | 2.336 | 1.358 | 2.902 | 1.578 | 1.518 | 1.055 | 1.154 | 2.388 | 2.082 | -37.611 | 1.481 | 1.644 | -22.668 | -20.099 | -17.973 | -11.477 | -7.709 | -7.443 | -4.186 | -4.2 | -4.449 | -2.309 | -1.262 |
| Gross Profit Ratio
| 0 | 0.752 | 1 | 0.664 | 0.819 | 0.72 | 0.539 | 0.456 | 0.517 | 0.862 | 0.839 | -17.269 | 0.825 | 0.888 | -10.48 | -7.71 | -6.647 | -5.358 | -4.415 | -4.83 | -3.082 | -2.907 | -6.845 | -10.308 | 0 |
| Reseach & Development Expenses
| 99.49 | 95.625 | 77.197 | 63.94 | 66.832 | 52.817 | 47.714 | 42.672 | 47.765 | 45.61 | 37.317 | 39.789 | 27.688 | 32.968 | 24.831 | 22.706 | 20.677 | 13.619 | 9.455 | 8.984 | 5.544 | 5.645 | 5.099 | 2.533 | 1.262 |
| General & Administrative Expenses
| 33.6 | 28.338 | 23.273 | 20.731 | 13.898 | 16.119 | 13.729 | 12.278 | 12.064 | 10.384 | 10.094 | 8.688 | 8.567 | 7.431 | 6.612 | 6.268 | 5.884 | 4.816 | 3.757 | 2.925 | 1.964 | 1.847 | 0.757 | 1.596 | 0.912 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | -0.641 | -0.615 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 33.6 | 28.338 | 23.273 | 20.731 | 13.257 | 15.504 | 13.729 | 12.278 | 12.064 | 10.384 | 10.094 | 8.688 | 8.567 | 7.431 | 6.612 | 6.268 | 5.884 | 4.816 | 3.757 | 2.925 | 1.964 | 1.847 | 0.757 | 1.596 | 0.912 |
| Other Expenses
| 0 | 0 | 0 | 0 | -0.101 | -0.105 | -0.013 | -0.162 | 5.202 | 2.754 | -0.012 | -0.002 | -0.025 | 0.009 | -0.011 | -0.002 | -0.003 | 0.018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 133.09 | 123.963 | 100.47 | 84.671 | 80.089 | 68.321 | 61.443 | 54.95 | 59.829 | 55.994 | 47.411 | 48.477 | 36.255 | 40.399 | 31.443 | 28.974 | 26.561 | 18.435 | 13.212 | 11.909 | 7.508 | 7.492 | 5.856 | 4.129 | 2.174 |
| Operating Income
| -131.517 | -120.99 | -98.134 | -82.626 | -77.187 | -66.743 | -58.625 | -52.634 | -52.785 | -53.225 | -44.929 | -46.299 | -34.46 | -38.547 | -29.28 | -26.367 | -23.857 | -16.293 | -11.466 | -10.368 | -6.15 | -6.047 | -5.206 | -3.905 | -2.174 |
| Operating Income Ratio
| -83.609 | -40.696 | -42.009 | -40.404 | -21.786 | -30.435 | -20.804 | -22.726 | -23.639 | -19.222 | -18.102 | -21.258 | -19.198 | -20.814 | -13.537 | -10.114 | -8.823 | -7.606 | -6.567 | -6.728 | -4.529 | -4.185 | -8.009 | -17.433 | 0 |
| Total Other Income Expenses Net
| 15.744 | 18.733 | 17.736 | 11.833 | 8.332 | 6.3 | 6.267 | 5.609 | 5.202 | 2.754 | 1.33 | 0.609 | 0.225 | 0.009 | 0.006 | 0.014 | 0.013 | 0.018 | 0.027 | -0.188 | 0.065 | -4.354 | -1.462 | -1.211 | -0.375 |
| Income Before Tax
| -115.773 | -102.257 | -80.398 | -70.793 | -68.855 | -60.443 | -52.358 | -47.025 | -52.394 | -50.471 | -43.599 | -45.69 | -34.235 | -38.538 | -29.274 | -26.353 | -23.844 | -16.275 | -11.439 | -10.556 | -6.085 | -10.401 | -6.668 | -5.116 | -2.549 |
| Income Before Tax Ratio
| -73.6 | -34.395 | -34.417 | -34.618 | -19.434 | -27.562 | -18.58 | -20.304 | -23.464 | -18.227 | -17.566 | -20.978 | -19.072 | -20.809 | -13.534 | -10.109 | -8.818 | -7.598 | -6.552 | -6.85 | -4.481 | -7.198 | -10.258 | -22.839 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.598 | 0 | -6.28 | -5.771 | -5.202 | -2.754 | -1.33 | -0.611 | -0.225 | -0.009 | -0.006 | -0.014 | -0.013 | -0.018 | -0.027 | 0.188 | -0.065 | 4.354 | 1.462 | 1.211 | 0.375 |
| Net Income
| -115.773 | -102.257 | -80.398 | -70.793 | -68.855 | -60.443 | -52.358 | -47.025 | -47.192 | -47.717 | -42.269 | -45.69 | -34.01 | -38.529 | -29.274 | -26.353 | -23.844 | -16.275 | -11.439 | -10.556 | -6.085 | -10.401 | -6.668 | -5.116 | -2.549 |
| Net Income Ratio
| -73.6 | -34.395 | -34.417 | -34.618 | -19.434 | -27.562 | -18.58 | -20.304 | -21.134 | -17.233 | -17.03 | -20.978 | -18.947 | -20.804 | -13.534 | -10.109 | -8.818 | -7.598 | -6.552 | -6.85 | -4.481 | -7.198 | -10.258 | -22.839 | 0 |
| EPS
| -0.9 | -0.8 | -0.65 | -0.66 | -0.79 | -0.79 | -0.71 | -0.66 | -0.67 | -0.83 | -0.8 | -0.92 | -0.71 | -1.63 | -0.68 | -0.7 | -0.64 | -0.43 | -0.31 | -1.23 | -0.2 | -0.5 | -0.32 | -0.25 | -0.12 |
| EPS Diluted
| -0.9 | -0.8 | -0.65 | -0.66 | -0.79 | -0.79 | -0.71 | -0.66 | -0.67 | -0.83 | -0.8 | -0.92 | -0.7 | -1.63 | -0.68 | -0.7 | -0.64 | -0.43 | -0.31 | -1.23 | -0.2 | -0.5 | -0.32 | -0.25 | -0.12 |
| EBITDA
| -131.517 | -120.252 | -97.424 | -82.626 | -76.546 | -66.128 | -58.059 | -52.105 | -57.205 | -50.09 | -44.559 | -45.977 | -34.146 | -38.33 | -29.104 | -26.22 | -23.749 | -16.16 | -11.338 | -10.368 | -5.924 | -5.98 | -5.122 | -3.817 | -2.081 |
| EBITDA Ratio
| -83.609 | -40.448 | -41.705 | -40.404 | -21.605 | -30.154 | -20.603 | -22.498 | -25.618 | -18.09 | -17.953 | -21.11 | -19.023 | -20.697 | -13.455 | -10.058 | -8.783 | -7.544 | -6.494 | -6.728 | -4.362 | -4.138 | -7.88 | -17.04 | 0 |